Health Cor Management, L.P. Rocket Pharmaceuticals, Inc. Transaction History
Health Cor Management, L.P.
- $106 Million
- Q4 2022
A detailed history of Health Cor Management, L.P. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Health Cor Management, L.P. holds 50,000 shares of RCKT stock, worth $923,000. This represents 0.92% of its overall portfolio holdings.
Number of Shares
50,000
Previous 445,140
88.77%
Holding current value
$923,000
Previous $7.1 Million
86.23%
% of portfolio
0.92%
Previous 0.89%
Shares
5 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$327 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$169 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$107 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$79.9 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.4B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...